BlackRock Inc. - THERAPEUTICS ACQUISITION COR ownership

Quarter-by-quarter ownership
BlackRock Inc. ownership history of THERAPEUTICS ACQUISITION COR
ValueSharesWeighting
Q2 2021$15,358,000
-2.6%
1,494,816
-0.3%
0.00%
Q1 2021$15,765,000
-24.5%
1,500,0000.0%0.00%
-100.0%
Q4 2020$20,880,000
-3.2%
1,500,0000.0%0.00%0.0%
Q3 2020$21,570,0001,500,0000.00%
Other shareholders
THERAPEUTICS ACQUISITION COR shareholders Q3 2021
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 864,214$8,875,0003.65%
BVF INC/IL 2,772,226$28,498,0001.07%
Johnson & Johnson Innovation - JJDC, Inc. 1,000,000$10,274,0001.05%
Boxer Capital, LLC 2,500,000$25,675,0000.91%
BERYLSON CAPITAL PARTNERS, LLC 386,221$3,968,0000.88%
SPHERA FUNDS MANAGEMENT LTD. 1,009,497$10,378,0000.70%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,045,600$21,017,0000.31%
FIRETHORN WEALTH PARTNERS, LLC 29,485$303,0000.25%
RA Capital Management 1,098,318$11,284,0000.18%
FARALLON CAPITAL MANAGEMENT LLC 2,400,000$24,672,0000.10%
View complete list of THERAPEUTICS ACQUISITION COR shareholders